AQP4 and myeloid sarcoma: In addition, patients with AQP4-IgG- and MOG-IgG-negative MS/NMOSD-like syndrome were not included because we could not confirm the pathological diagnosis in this group; hence, we could not evaluate the diagnostic performance of the criteria in these patients.